Exploring Scaffold Hopping for Novel 2-(Quinolin-4-yloxy)acetamides with Enhanced Antimycobacterial Activity-Reference-Cited by-同舟云学术

Exploring Scaffold Hopping for Novel 2-(Quinolin-4-yloxy)acetamides with Enhanced Antimycobacterial Activity

Published:2024-03-11 Issue:4 Volume:15 Page:493-500
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Borsoi Ana Flávia¹²,Silva Ramos Alessandro¹,Sperotto Nathalia¹,Abbadi Bruno Lopes¹,Souza Macchi Hopf Fernanda¹³,da Silva Dadda Adilio¹,Scheibler Rambo Raoní¹,Neves Muniz Mauro¹,Delgado Paz Josiane¹,Silveira Grams Estevão¹³,Fries da Silva Fernanda¹³,Pissinate Kenia¹,Galina Luiza¹,Calle González Laura¹³,Silva Duarte Lovaine¹,Alberton Perelló Marcia¹,de Matos Czeczot Alexia¹³,Bizarro Cristiano Valim¹³^ORCID,Basso Luiz Augusto¹²³^ORCID,Machado Pablo¹²³^ORCID

Affiliation:

1. Instituto Nacional de Ciência e Tecnologia em Tuberculose, Centro de Pesquisas em Biologia Molecular e Funcional, Pontifícia Universidade Católica do Rio Grande do Sul, 90616-900 Porto Alegre, Rio Grande do Sul, Brazil

2. Programa de Pós-Graduação em Medicina e Ciências da Saúde, Pontifícia Universidade Católica do Rio Grande do Sul, 90616-900 Porto Alegre, Rio Grande do Sul, Brazil

3. Programa de Pós-Graduação em Biologia Celular e Molecular, Pontifícia Universidade Católica do Rio Grande do Sul, 90616-900 Porto Alegre, Rio Grande do Sul, Brazil

Funder

Instituto Nacional de Ci?ncia e Tecnologia em Tuberculose

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.3c00570

Reference24 articles.

1. Global tuberculosis report 2023. World Health Organization. Available from: https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2023, (accessed in December 2023).

2. WHO Report: Years of Progress in Global Tuberculosis Upset by COVID-19 Pandemic

3. The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis

4. Delamanid for Multidrug-Resistant Pulmonary Tuberculosis

5. A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis